Literature DB >> 32486831

Decreased endothelial glycocalyx thickness is an early predictor of mortality in sepsis.

Daniëlle Mh Beurskens1,2, Martine E Bol3,4, Tammo Delhaas2,5, Marcel Cg van de Poll3,4,6, Chris Pm Reutelingsperger1,2, Gerry Af Nicolaes1,2, Jan-Willem Em Sels3,7.   

Abstract

Microcirculatory alterations play an important role in the early phase of sepsis. Shedding of the endothelial glycocalyx is regarded as a central pathophysiological mechanism causing microvascular dysfunction, contributing to multiple organ failure and death in sepsis. The objective of this study was to investigate whether endothelial glycocalyx thickness at an early stage in septic patients relates to clinical outcome. We measured the perfused boundary region (PBR), which is inversely proportional to glycocalyx thickness, of sublingual microvessels (5-25 µm) using sidestream dark field imaging. The PBR in 21 patients with sepsis was measured within 24 h of admission to the intensive care unit (ICU). In addition, we determined plasma markers of microcirculatory dysfunction and studied their correlation with PBR and mortality. Endothelial glycocalyx thickness in sepsis was significantly lower for non-survivors as compared with survivors, indicated by a higher PBR of 1.97 [1.85, 2.19]µm compared with 1.76 [1.59, 1.97] µm, P=0.03. Admission PBR was associated with hospital mortality with an area under the curve of 0.778 based on the receiver operating characteristic curve. Furthermore, PBR correlated positively with angiopoietin-2 (rho=0.532, P=0.03), indicative of impaired barrier function. PBR did not correlate with Acute Physiology and Chronic Health Evaluation IV (APACHE IV), Sequential Organ Failure Assessment score (SOFA score), lactate, syndecan-1, angiopoietin-1 or heparin-binding protein. An increased PBR within the first 24 h after ICU admission is associated with mortality in sepsis. Further research should be aimed at the pathophysiological importance of glycocalyx shedding in the development of multi-organ failure and at therapies attempting to preserve glycocalyx integrity.

Entities:  

Keywords:  Sepsis; haemodynamic monitoring; imaging modalities; intensive care; microcirculation; multiple organ dysfunction

Year:  2020        PMID: 32486831     DOI: 10.1177/0310057X20916471

Source DB:  PubMed          Journal:  Anaesth Intensive Care        ISSN: 0310-057X            Impact factor:   1.669


  9 in total

1.  Degradation of endothelial glycocalyx in Tanzanian children with falciparum malaria.

Authors:  Margaret A Bush; Salvatore M Florence; Tsin W Yeo; Ayam R Kalingonji; Youwei Chen; Donald L Granger; Matthew P Rubach; Nicholas M Anstey; Esther D Mwaikambo; Joe Brice Weinberg
Journal:  FASEB J       Date:  2021-09       Impact factor: 5.834

Review 2.  Endothelial Activation and Microcirculatory Disorders in Sepsis.

Authors:  Lisa Raia; Lara Zafrani
Journal:  Front Med (Lausanne)       Date:  2022-06-03

Review 3.  Targeting the "sweet spot" in septic shock - A perspective on the endothelial glycocalyx regulating proteins Heparanase-1 and -2.

Authors:  Thorben Pape; Anna Maria Hunkemöller; Philipp Kümpers; Hermann Haller; Sascha David; Klaus Stahl
Journal:  Matrix Biol Plus       Date:  2021-12-02

4.  Prognostic Value of Syndecan-1 in the Prediction of Sepsis-Related Complications and Mortality: A Meta-Analysis.

Authors:  Ting Sun; Yuqiong Wang; Xiaojing Wu; Ying Cai; Tianshu Zhai; Qingyuan Zhan
Journal:  Front Public Health       Date:  2022-04-11

5.  Assessment of sublingual microcirculation for the screening of diabetic nephropathy.

Authors:  Qiang Li; XiaoXiao Liu; Mengxiao Jia; Fang Sun; Yingsha Li; Hexuan Zhang; Xiaoli Liu; Hongbo He; Zhigang Zhao; Zhencheng Yan; Zhiming Zhu
Journal:  Diabetol Metab Syndr       Date:  2022-07-06       Impact factor: 5.395

Review 6.  Endothelial Glycocalyx Degradation in Critical Illness and Injury.

Authors:  Eric K Patterson; Gediminas Cepinskas; Douglas D Fraser
Journal:  Front Med (Lausanne)       Date:  2022-07-08

7.  A possible pathogenic role of Syndecan-1 in the pathogenesis of coronavirus disease 2019 (COVID-19).

Authors:  Sajad Karampoor; Hamid Zahednasab; Mohammad Farahmand; Rasoul Mirzaei; Farhad Zamani; Alireza Tabibzadeh; Behnaz Bouzari; Hossein Ajdarkosh; Mehdi Nikkhah; Melika Razavi Hashemi; Azadeh Laali; Hossein Keyvani
Journal:  Int Immunopharmacol       Date:  2021-04-17       Impact factor: 5.714

Review 8.  Glycocalyx as Possible Limiting Factor in COVID-19.

Authors:  Patricia P Wadowski; Bernd Jilma; Christoph W Kopp; Sebastian Ertl; Thomas Gremmel; Renate Koppensteiner
Journal:  Front Immunol       Date:  2021-02-22       Impact factor: 7.561

9.  Metabolic Response in Endothelial Cells to Catecholamine Stimulation Associated with Increased Vascular Permeability.

Authors:  Adrián López García de Lomana; Arnar Ingi Vilhjálmsson; Sarah McGarrity; Rósa Sigurðardóttir; Ósk Anuforo; Alexía Rós Viktorsdóttir; Aris Kotronoulas; Andreas Bergmann; Leifur Franzson; Haraldur Halldórsson; Hanne H Henriksen; Charles E Wade; Pär Ingemar Johansson; Óttar Rolfsson
Journal:  Int J Mol Sci       Date:  2022-03-15       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.